Is Tejnaksh Healthcare a good stock to invest in?

Tejnaksh Healthcare can be analyzed on the following key metrics - TTM P/E: 18.46 Sector P/E: 22.75 Dividend Yield: 0% D/E ratio: -

Tejnaksh Healthcare Share Price

Sector: Healthcare Facilities

Powered by

22.25 +0.61 (2.82%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 21.62

Today’s High 22.50

52 Week Low 20.50

52 Week High 30.50

Key Metrics

Market Cap (In Cr) 45.4
Beta 0.69
Div. Yield (%) 0
P/B 1.93
TTM P/E 18.46
Peg Ratio -3.76
Sector P/E 22.75
Open Price 22.3
Prev Close 21.64

View All Metrics

Tejnaksh Healthcare Analysis

Price Analysis

1 Week

2.1%
3 Months

-7.18%
6 Month

-5.89%
YTD

-0.67%
1 Year

-8.25%

Risk Meter

45% Low risk
45% Moderate risk
45% Balanced Risk
45% High risk
45% Extreme risk

Tejnaksh Healthcare News

Premium

Tejnaksh Healthcare Q1 Results Live: profit rise by 273.7% YOY

1 min read . 16 Aug 2024

Among the Sensex stocks, Bajaj Finserv, Bajaj Finance, IndusInd Bank, Tech Mahindra, and ICICI Bank ended between 4% and 5.5%

Premium

Healthcare stock trading at a discount of 58% from 52-week-high declares 1:2 stock split

1 min read . 20 May 2023

View More News

Tejnaksh Healthcare Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2024

Total Revenue
12.18

Selling/ General/ Admin Expenses Total
2.39

Depreciation/ Amortization
0.91

Other Operating Expenses Total
4.82

Total Operating Expense
9.38

Operating Income
2.79

Net Income Before Taxes
2.38

Net Income
1.78

Diluted Normalized EPS
0.87

Period
2023

Total Revenue
11.73

Selling/ General/ Admin Expenses Total
1.95

Depreciation/ Amortization
0.87

Other Operating Expenses Total
4.54

Total Operating Expense
8.77

Operating Income
2.96

Net Income Before Taxes
2.51

Net Income
1.68

Diluted Normalized EPS
0.83

Period
2022

Total Revenue
12.68

Selling/ General/ Admin Expenses Total
1.31

Depreciation/ Amortization
0.67

Other Operating Expenses Total
5.15

Total Operating Expense
8.54

Operating Income
4.13

Net Income Before Taxes
3.76

Net Income
2.72

Diluted Normalized EPS
1.36

Period
2021

Total Revenue
11.96

Selling/ General/ Admin Expenses Total
1.39

Depreciation/ Amortization
0.68

Other Operating Expenses Total
5.97

Total Operating Expense
8.93

Operating Income
3.03

Net Income Before Taxes
2.67

Net Income
2.05

Diluted Normalized EPS
1.01

Period
2020

Total Revenue
16.76

Selling/ General/ Admin Expenses Total
2.55

Depreciation/ Amortization
0.65

Other Operating Expenses Total
9.23

Total Operating Expense
13.73

Operating Income
3.03

Net Income Before Taxes
2.97

Net Income
2.09

Diluted Normalized EPS
1.03

Period
2019

Total Revenue
19.76

Selling/ General/ Admin Expenses Total
2.93

Depreciation/ Amortization
0.59

Other Operating Expenses Total
11.45

Total Operating Expense
16.17

Operating Income
3.59

Net Income Before Taxes
4.36

Net Income
3.03

Diluted Normalized EPS
1.49

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Tejnaksh Healthcare Technical

Moving Average SMA

5 Day21.84
10 Day21.73
20 Day22.15

50 Day22.42
100 Day23.64
300 Day24.11

Tejnaksh Healthcare Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Aspira Pathlab & Diagnostics
61.6
0
0
106.78
25
63.41

N G Industries
163.7
0
0
205.5
145
54.85

Tejnaksh Healthcare
22.25
0.61
2.82
30.5
20.5
45.4

Medinova Diagnostic Services
39.25
-0.08
-0.2
51.05
32.1
39.18

Samsrita Labs
21.53
0
0
32.36
12.19
31.88

Tejnaksh Healthcare Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

12-Apr-25
Others

11-Feb-25
Quarterly Results

23-Jan-25
Rights issue of Equity Shares

14-Nov-24
Quarterly Results

14-Aug-24
Quarterly Results

28-May-24
Audited Results

12-Feb-24
Quarterly Results

11-Nov-23
Quarterly Results

12-Aug-23
Quarterly Results

20-May-23
Audited Results & Stock Split

Meeting Date
Announced on
Purpose

22-Feb-25
30-Jan-25
EGM

28-Sept-24
05-Sept-24
AGM

21-Sept-23
30-Aug-23
AGM

26-Jun-23
24-May-23
POM

Ex-Splits
Old FV
New FV
Description

19-Jul-23
10
5
Stock split from Rs. 10/- to Rs. 5/-.

View All

Company Profile

ABOUT Tejnaksh Healthcare

Industry Healthcare Facilities
ISIN INE030T01027
BSE Code 539428

Tejnaksh Healthcare Limited is an India-based holding company, which is engaged in the healthcare services and pharmacies business. The Company is focused on the provision of hospital and healthcare services in Mumbai and other parts of Maharashtra. The Company operates through one segment: Medical and Healthcare Services. The Company's domains include Multi-specialty Hospital, Super Specialty Hospital, Pathology Lab, research and development, pharmaceutical, Healthcare Equipment, Super Specialty Training Institutes, Stone Analysis Lab Education Institutes, and Simulation Institute. Its Healthcare Equipment includes a stone manipulation simulator, an ultrasound guided perc simulator, and a radiation-free perc simulator. It provides healthcare services at approximately 13 urology clinics, four urology hospitals, and two dental superspecialist clinics.

MANAGEMENT

Ramesh Kuwar Chief Financial Officer
Shaikh Afrinas Compliance Officer, Company Secretary
Ashish Rawandale Managing Director, Executive Director
Yaser Ahmedd Resident Urology
Gautam Ladumor Resident Urology
Lokesh Patni Resident Urology

TEJNAKSH HEALTHCARE SUMMARY

Tejnaksh Healthcare is trading 2.82% upper at Rs 22.25 as compared to its last closing price. Tejnaksh Healthcare has been trading in the price range of 22.50 & 21.62. Tejnaksh Healthcare has given -0.67% in this year & 2.1% in the last 5 days.

Tejnaksh Healthcare has TTM P/E ratio 18.46 as compared to the sector P/E of 22.75.

The company posted a net profit of 0.56 Crores in its last quarter.

Listed peers of Tejnaksh Healthcare include Aspira Pathlab & Diagnostics (0%), N G Industries (0%), Tejnaksh Healthcare (2.82%) etc.

Tejnaksh Healthcare has a 73.83% promoter holding & 26.17% public holding.

FAQs about Tejnaksh Healthcare

Tejnaksh Healthcare is trading at 22.25 as on 21 May, 2025 9:00:04 AM. This is 2.82% upper as compared to its previous closing price of 21.64

The market capitalization of Tejnaksh Healthcare is 45.4 Cr as on 21 May, 2025 9:00:04 AM.

The 52 wk high for Tejnaksh Healthcare is 30.50 whereas the 52 wk low is 20.50

Tejnaksh Healthcare can be analyzed on the following key metrics -

TTM P/E: 18.46
Sector P/E: 22.75
Dividend Yield: 0%
D/E ratio: -

Tejnaksh Healthcare reported a net profit of 1.78 Cr in 2024.

Tejnaksh Healthcare Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Tejnaksh Healthcare Share Price

Price Range

Key Metrics

Tejnaksh Healthcare Analysis

Tejnaksh Healthcare News

Tejnaksh Healthcare Q1 Results Live: profit rise by 273.7% YOY

Healthcare stock trading at a discount of 58% from 52-week-high declares 1:2 stock split

Tejnaksh Healthcare Financials

Forecast

Forecast

Forecast

Tejnaksh Healthcare Technical

Tejnaksh Healthcare Peers

Tejnaksh Healthcare Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Tejnaksh Healthcare

MANAGEMENT

TEJNAKSH HEALTHCARE SUMMARY

FAQs about Tejnaksh Healthcare

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue